magent
Deterministic published-formula arithmetic plus ICD-10-CM, RxNorm, and LOINC. Pay in USDC on Base via x402.
Mediaofflineeip155:8453Exactvia cdp
Smm-22020SmmMyelomaHematologyCalculator
Calls · 30d
1→ 0%
This endpoint's own trailing-30-day call count, as published by the upstream catalog and snapshotted daily. 8 snapshots so far.
$13.75
Verified settled volume
2,750 settlements proven x402 by their on-chain EIP-3009 marker.
$0.0050
Listed price
As published in the catalog. Always read the live 402 before paying.
1
Calls · 30d
Upstream's own call count for this endpoint, not ours.
1
Unique payers · 30d
Last called 2026-09-01 23:29Z
—
Upstream on-chain volume
Reported by the source catalog.
Paid to
0x836Be278f1739fB4308091cD1852F7971Bc19Ee2The wallet the 402 directs payment to. Its whole payment record — every payer, every chain — is on the merchant page.
Asset 0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913
Provider
The payTo wallet does not resolve to a registered ERC-8004 agent. That is not a verdict on the service — most of the catalog is unregistered.
Live 402 challenge
Captured by the enrichment pass, not read just now. Prices can change — always read the 402 the endpoint answers with.
{
"error": "PAYMENT-SIGNATURE header is required",
"accepts": [
{
"asset": "0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913",
"extra": {
"name": "USD Coin",
"version": "2",
"paymentFlow": "upfront",
"resourceUrl": "https://api.magentlab.com/api/calc/smm_22020",
"assetTransferMethod": "eip3009"
},
"payTo": "0x836Be278f1739fB4308091cD1852F7971Bc19Ee2",
"amount": "5000",
"scheme": "exact",
"network": "eip155:8453",
"maxTimeoutSeconds": 600
},
{
"asset": "0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913",
"extra": {
"name": "USD Coin",
"version": "2",
"withdrawDelay": 86400,
"receiverAuthorizer": "0x3721824a31197dcDD2984cF43b92B6cc8A87c0Fb",
"assetTransferMethod": "eip3009"
},
"payTo": "0x836Be278f1739fB4308091cD1852F7971Bc19Ee2",
"amount": "5000",
"scheme": "batch-settlement",
"network": "eip155:8453",
"maxTimeoutSeconds": 600
}
],
"resource": {
"url": "https://api.magentlab.com/api/calc/smm_22020",
"tags": [
"smm-22020",
"smm",
"myeloma",
"hematology",
"calculator"
],
"mimeType": "application/json",
"description": "Lakshman 2018 2/20/20 smoldering myeloma risk: one point each for BMPC >20%, serum M-protein >2 g/dL, and involved/uninvolved FLC ratio >20 (strict greater-than). 0 factors low (median TTP 110 months), 1 intermediate (68), 2 or 3 high (29). Not Mayo 70/20, not PETHEMA, not myeloma ISS, not a treatment order. BMPC 10-59 and FLC 0.01-99.9 (IMWG 2014 SLiM myeloma is rejected). magent does not assay marrow, M-protein, or free light chains.",
"serviceName": "magent"
},
"extensions": {
"bazaar": {
"info": {
"input": {
"type": "http",
"method": "GET",
"queryParams": {
"flc_ratio": 25,
"bmpc_percent": 25,
"m_protein_g_dl": 2.5
}
},
"output": {
"type": "json",
"example": {
"score": 3,
"formula": "smm_22020",
"citation": {
"id": "lakshman-2018",
"doi": "10.1038/s41408-018-0077-4",
"pmid": "29895887",
"title": "Risk stratification of smoldering multiple myeloma incorporating revised IMWG diagnostic criteria",
"source": "Blood Cancer J. 2018;8(6):59",
"authors": "Lakshman A, Rajkumar SV, Buadi FK, et al."
},
"flc_ratio": 25,
"max_score": 3,
"components": [
{
"value": 25,
"factor": "bmpc_percent_gt_20",
"points": 1,
"present": true
},
{
"value": 2.5,
"factor": "m_protein_gt_2",
"points": 1,
"present": true
},
{
"value": 25,
"factor": "flc_ratio_gt_20",
"points": 1,
"present": true
}
],
"disclaimer": "Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.",
"risk_group": "high",
"bmpc_percent": 25,
"factor_count": 3,
"m_protein_g_dl": 2.5,
"median_ttp_months": 29,
"formula_expression": "Lakshman 2018 2/20/20 = (bmpc_percent > 20) + (m_protein_g_dl > 2) + (flc_ratio > 20); each 1; max 3; 0 low median TTP 110 months, 1 intermediate 68 months, 2 or 3 high 29 months. Not Mayo 70/20. Not PETHEMA. Not myeloma ISS"
}
},
"iconUrl": "https://api.magentlab.com/favicon.ico"
},
"schema": {
"type": "object",
"$schema": "https://json-schema.org/draft/2020-12/schema",
"required": [
"input"
],
"properties": {
"input": {
"type": "object",
"required": [
"type",
"method"
],
"properties": {
"type": {
"type": "string",
"const": "http"
},
"method": {
"enum": [
"GET",
"HEAD",
"DELETE"
],
"type": "string"
},
"headers": {
"type": "object",
"additionalProperties": {
"type": "string"
}
},
"queryParams": {
"type": "object",
"required": [
"bmpc_percent",
"m_protein_g_dl",
"flc_ratio"
],
"properties": {
"flc_ratio": {
"type": "number",
"description": "Involved/uninvolved serum free light-chain ratio as assigned by the caller (0.01-99.9). >20 scores 1 (Lakshman 2018 2/20/20). 20 scores 0. 100 or above is IMWG 2014 myeloma and is rejected, not scored. magent does not assay free light chains."
},
"bmpc_percent": {
"type": "number",
"description": "Bone-marrow plasma cells as a percent (10-59). >20 scores 1 (Lakshman 2018 2/20/20). 20 scores 0. 10 is the SMM floor. 60 or above is IMWG 2014 myeloma and is rejected, not scored. magent does not read a marrow."
},
"m_protein_g_dl": {
"type": "number",
"description": "Serum M-protein in g/dL (0-15). >2 scores 1 (Lakshman 2018 2/20/20). 2 scores 0. magent does not assay M-protein."
}
}
}
},
"additionalProperties": false
},
"output": {
"type": "object",
"required": [
"type"
],
"properties": {
"type": {
"type": "string"
},
"example": {
"type": "object"
}
}
}
}
}
}
},
"x402Version": 2
}Accepts
The payment requirements as published to the catalog. Read the live 402 before paying — a price here is a claim, not a quote.
0.005USDC≈ $0.005 USD
on Base · exact scheme
Pay 0.005 USDC on Base to 0x836B…19Ee2. The signed payment is good for 10 minutes.
- Paid to
- 0x836B…19Ee2
- USD Coin contract
- 0x8335…02913
- Payment window
- 10 minutes
- As published
- 5000 smallest units
The catalog’s raw entry
[
{
"asset": "0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913",
"extra": {
"name": "USD Coin",
"version": "2",
"paymentFlow": "upfront",
"resourceUrl": "https://api.magentlab.com/api/calc/smm_22020",
"assetTransferMethod": "eip3009"
},
"payTo": "0x836Be278f1739fB4308091cD1852F7971Bc19Ee2",
"amount": "5000",
"scheme": "exact",
"network": "eip155:8453",
"maxTimeoutSeconds": 600
}
]Extensions
{
"bazaar": {
"info": {
"input": {
"body": {
"items": [
{
"flc_ratio": 25,
"bmpc_percent": 25,
"m_protein_g_dl": 2.5
},
{
"flc_ratio": 25,
"bmpc_percent": 25,
"m_protein_g_dl": 2.5
}
]
},
"type": "http",
"method": "POST"
},
"output": {
"type": "json",
"example": {
"path": "/api/calc/smm_22020",
"count": 2,
"items": [
{
"score": 3,
"formula": "smm_22020",
"citation": {
"id": "lakshman-2018",
"doi": "10.1038/s41408-018-0077-4",
"pmid": "29895887",
"title": "Risk stratification of smoldering multiple myeloma incorporating revised IMWG diagnostic criteria",
"source": "Blood Cancer J. 2018;8(6):59",
"authors": "Lakshman A, Rajkumar SV, Buadi FK, et al."
},
"flc_ratio": 25,
"max_score": 3,
"components": [
{
"value": 25,
"factor": "bmpc_percent_gt_20",
"points": 1,
"present": true
},
{
"value": 2.5,
"factor": "m_protein_gt_2",
"points": 1,
"present": true
},
{
"value": 25,
"factor": "flc_ratio_gt_20",
"points": 1,
"present": true
}
],
"disclaimer": "Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.",
"risk_group": "high",
"bmpc_percent": 25,
"factor_count": 3,
"m_protein_g_dl": 2.5,
"median_ttp_months": 29,
"formula_expression": "Lakshman 2018 2/20/20 = (bmpc_percent > 20) + (m_protein_g_dl > 2) + (flc_ratio > 20); each 1; max 3; 0 low median TTP 110 months, 1 intermediate 68 months, 2 or 3 high 29 months. Not Mayo 70/20. Not PETHEMA. Not myeloma ISS"
},
{
"score": 3,
"formula": "smm_22020",
"citation": {
"id": "lakshman-2018",
"doi": "10.1038/s41408-018-0077-4",
"pmid": "29895887",
"title": "Risk stratification of smoldering multiple myeloma incorporating revised IMWG diagnostic criteria",
"source": "Blood Cancer J. 2018;8(6):59",
"authors": "Lakshman A, Rajkumar SV, Buadi FK, et al."
},
"flc_ratio": 25,
"max_score": 3,
"components": [
{
"value": 25,
"factor": "bmpc_percent_gt_20",
"points": 1,
"present": true
},
{
"value": 2.5,
"factor": "m_protein_gt_2",
"points": 1,
"present": true
},
{
"value": 25,
"factor": "flc_ratio_gt_20",
"points": 1,
"present": true
}
],
"disclaimer": "Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.",
"risk_group": "high",
"bmpc_percent": 25,
"factor_count": 3,
"m_protein_g_dl": 2.5,
"median_ttp_months": 29,
"formula_expression": "Lakshman 2018 2/20/20 = (bmpc_percent > 20) + (m_protein_g_dl > 2) + (flc_ratio > 20); each 1; max 3; 0 low median TTP 110 months, 1 intermediate 68 months, 2 or 3 high 29 months. Not Mayo 70/20. Not PETHEMA. Not myeloma ISS"
}
]
}
},
"iconUrl": "https://api.magentlab.com/favicon.ico"
},
"schema": {
"type": "object",
"$schema": "https://json-schema.org/draft/2020-12/schema",
"required": [
"input"
],
"properties": {
"input": {
"type": "object",
"required": [
"type",
"method"
],
"properties": {
"body": {
"type": "object",
"required": [
"items"
],
"properties": {
"items": {
"type": "array",
"items": {
"type": "object",
"required": [
"bmpc_percent",
"m_protein_g_dl",
"flc_ratio"
],
"properties": {
"flc_ratio": {
"type": "number",
"description": "Involved/uninvolved serum free light-chain ratio as assigned by the caller (0.01-99.9). >20 scores 1 (Lakshman 2018 2/20/20). 20 scores 0. 100 or above is IMWG 2014 myeloma and is rejected, not scored. magent does not assay free light chains."
},
"bmpc_percent": {
"type": "number",
"description": "Bone-marrow plasma cells as a percent (10-59). >20 scores 1 (Lakshman 2018 2/20/20). 20 scores 0. 10 is the SMM floor. 60 or above is IMWG 2014 myeloma and is rejected, not scored. magent does not read a marrow."
},
"m_protein_g_dl": {
"type": "number",
"description": "Serum M-protein in g/dL (0-15). >2 scores 1 (Lakshman 2018 2/20/20). 2 scores 0. magent does not assay M-protein."
}
}
},
"maxItems": 25,
"minItems": 1
}
},
"additionalProperties": false
},
"type": {
"type": "string",
"const": "http"
},
"method": {
"type": "string",
"const": "POST"
},
"headers": {
"type": "object",
"additionalProperties": {
"type": "string"
}
}
},
"additionalProperties": false
},
"output": {
"type": "object",
"required": [
"type"
],
"properties": {
"type": {
"type": "string"
},
"example": {
"type": "object"
}
}
}
}
}
}
}Provenance
- Seen in the source catalog
- 2026-09-01 23:29Z
- Last indexed by Roundhouse
- 2026-09-07 06:20Z
- Last enriched (probe, favicon, geo)
- 2026-09-10 14:46Z
- x402 version
- 2
- Max timeout
- 600s
- Liveness probe
- HTTP 0
Hand this page to an agent
Copy the prompt and paste it into Claude, an MCP client or your own agent — it will vet this service and call it over the free read API. No key, no account.
GET api.roundhouseai.io/v0/endpoints
This endpoint's own trailing-30-day call count, as published by the upstream catalog and snapshotted daily. 8 snapshots so far. Verified volume counts only settlements with an on-chain EIP-3009 marker.
Show the promptHide the prompt
Using Roundhouse, look up the x402 service magent and tell me whether it is worth paying: what a call costs, whether the endpoint answered when last probed, and what its payment record actually shows. curl -s 'https://api.roundhouseai.io/v0/endpoints?q=magent' curl -s 'https://api.roundhouseai.io/v0/merchants/<the payTo wallet returned above>' Then call it: read the price from the live 402 at https://api.magentlab.com/api/calc/smm_22020, never from a cached figure, and pay with an x402 client. The /v0 API needs an API key (`authorization: Bearer rh_live_…`) on everything except /v0/unified* and /v0/endpoints. Mint a personal key for $0.01 at GET https://api.roundhouseai.io/v0/test/x402, or use an organization key from https://roundhouseai.io/dashboard/team. If you do not have Roundhouse tools or skills installed, read https://roundhouseai.io/skill.md first — it is the whole procedure.